IP Library Patent Application 18419408
Patent Application
App. No. 18/419,408

MEDICATION BLADDER FOR MEDICATION STORAGE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/419,408
Abstract

Systems and methods disclosed herein relate to a disease management device which includes at least one or more medication bladders, configured to store fluid and a medication delivery pump, configured to deliver a fluid from one or more medication bladders to a patient. Each medication bladder has at least a rigid portion and a flexible portion, the flexible portion coupled to the rigid portion to create an at least partially sealed enclosure. The rigid portion includes structures, such as channels, configured to facilitate emptying the medication bladder through an output port. On application of pressure from the pump, the flexible portion is configured to generate a pressure against the structures rigid portion, which facilitates emptying of fluid from the medication bladder through the output port.

Claims (66)

1 - 63 . (canceled)

64 . A disease management device comprising:

a pump configured to deliver fluid to an injection site of a patient;

one or more medication bladders configured to store the fluid prior to delivery to the injection site of the patient, each of the one or more medication bladders comprising:

a rigid portion coupled to a flexible portion to form an at least partially sealed enclosure, the rigid portion comprising:

an outlet port configured to allow an outward flow of the fluid from the at least partially sealed enclosure towards the pump,

wherein the flexible portion comprises a flexible material configured to change shape so as to facilitate movement of the fluid within the at least partially sealed enclosure towards the outlet port of the rigid portion.

65 . The disease management device of claim 64 ,

wherein the rigid portion further comprises a first interior surface, and

wherein the flexible portion further comprises a second interior surface,

and wherein the first interior surface and second interior surface further comprise an anti-aggregation coating, wherein the anti-aggregation coating facilitates the movement of fluid within the at least partially sealed enclosure towards the outlet port of the rigid portion.

66 . The disease management device of claim 64 , the rigid portion further comprising:

an inlet port configured to facilitate access to the partially sealed enclosure for filling the medication bladder with the fluid.

67 - 68 . (canceled)

69 . The disease management device of claim 64 , wherein the disease management device further comprises a pressure applicator configured to apply external pressure to at least one of the one or more medication bladders, wherein the applied external pressure is based on a force received by the pressure applicator from the pump.

70 - 73 . (canceled)

74 . The disease management device of claim 64 , the rigid portion further comprising:

an interior surface comprising:

a plurality of channels configured to extend from at least one edge of the rigid portion towards the outlet port.

75 . The disease management device of claim 74 , wherein the rigid portion further comprises one or more protrusions, wherein each channel of the plurality of channels forms a depression within a protrusion of the one or more protrusions, and wherein the depression is configured to facilitate movement of fluid within the at least partially sealed enclosure towards the outlet port.

76 . The disease management device of claim 74 , wherein the rigid portion further comprises one or more guiding surfaces, including at least one of a curved surfaces or an inclined surface,

wherein the one or more guiding surfaces apply contours to the rigid portion to facilitate the movement of fluid within the partially sealed enclosure towards the outlet port of the rigid portion, and

wherein the plurality of channels follow the contours of the rigid portion.

77 . The disease management device of claim 74 , wherein the flexible material of the flexible portion is configured to change shape at least by compressing against the plurality of channels of rigid portion, wherein compression of the flexible material against the plurality of channels of the rigid portion facilitates the movement of fluid with the at least partially sealed enclosure towards the outlet port of the rigid portion.

78 . (canceled)

79 . The disease management device of claim 64 , wherein the rigid portion further comprises:

one or more walls;

one or more edges;

a central region including the outlet port;

a top surface; and

one or more protruding structures,

wherein the one or more protruding structures extend vertically with respect to a major plane of the top surface,

wherein the one or more protruding structures extend from the at least of the one or more walls or one or more edges to the central region.

80 . The disease management device of claim 79 , wherein the one or more protruding structures vary in height with respect to a major plane of the top surface.

81 . A medication bladder comprising:

a rigid portion coupled to a flexible portion to form an at least partially sealed enclosure, the rigid portion comprising:

an outlet port configured to allow an outward flow of fluid from the at least partially sealed enclosure; and

the flexible portion, wherein the flexible portion comprises a flexible material configured to change shape so as to facilitate movement of the fluid within the at least partially sealed enclosure towards the outlet port of the rigid portion.

82 . The medication bladder of claim 81 :

wherein the rigid portion further comprises a first interior surface,

wherein the flexible portion further comprises a second interior surface, and

wherein the first interior surface and second interior surface further comprise an anti-aggregation coating, wherein the anti-aggregation coating facilitates the movement of fluid within the at least partially sealed enclosure towards the outlet port of the rigid portion.

83 . The medication bladder of claim 81 , the rigid portion further comprising:

an inlet port configured to facilitate access to the partially sealed enclosure for filling the medication bladder with the fluid.

84 . The medication bladder of claim 81 , the rigid portion further comprising:

an interior surface comprising:

a plurality of channels configured to extend from at least one edge of the rigid portion towards the outlet port.

85 . The medication bladder of claim 84 , wherein the rigid portion further comprises one or more protrusions, wherein each channel of the plurality of channels forms a depression within a protrusion of the one or more protrusions, and wherein the depression is configured to facilitate movement of fluid within the at least partially sealed enclosure towards the outlet port.

86 . The medication bladder of claim 84 :

wherein the rigid portion further comprises one or more guiding surfaces, including at least one of a curved surfaces or an inclined surface,

wherein the one or more guiding surfaces apply contours to the rigid portion to facilitate the movement of fluid within the partially sealed enclosure towards the outlet port of the rigid portion, and

wherein the plurality of channels follow the contours of the rigid portion.

87 . The medication bladder of claim 84 , wherein the flexible material of the flexible portion is configured to change shape at least by compressing against the plurality of channels of rigid portion, wherein compression of the flexible material against the plurality of channels of the rigid portion facilitates the movement of fluid with the at least partially sealed enclosure towards the outlet port of the rigid portion.

88 . The medication bladder of claim 81 , wherein the rigid portion further comprises:

one or more walls;

one or more edges;

a central region including the outlet port;

a top surface; and

one or more protruding structures,

wherein the one or more protruding structures extend vertically with respect to a major plane of the top surface,

wherein the one or more protruding structures extend from the at least of the one or more walls or one or more edges to the central region.

89 . The medication bladder of claim 88 , wherein the one or more protruding structures vary in height with respect to a major plane of the top surface.

90 . The medication bladder of claim 88 :

wherein the rigid portion further comprises an interior surface,

wherein the interior surface includes a plurality of channels; and

wherein a location each channel on the interior surface corresponds to a location for a protruding structure on the top surface.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2024
From: VO, HUNG THE; LEE, SAI KONG FRANK; TRAN, TUAN MINH; DABIRI-ASGARI, AMIR K.; DERAKHSHANDEH, HOSSEIN; JALALMANESH, POUYA
To: WILLOW LABORATORIES, INC.
Reel/Frame 067166/0072 →
CHANGE OF NAME Recorded Mar 21, 2024
From: CERCACOR LABORATORIES, INC.
To: WILLOW LABORATORIES, INC.
Reel/Frame 066867/0264 →
CHANGE OF NAME Recorded Mar 19, 2024
From: CERCACOR LABORATORIES, INC.
To: WILLOW LABORATORIES, INC.
Reel/Frame 066833/0454 →